Darolutamide For Castration-Resistant Prostate Cancer

The treatment landscape of advanced prostate cancer continues to evolve rapidly, with newer and more active drugs being used in earlier phases of the disease based on improved overall survival. After adoption of docetaxel for metastatic castration-sensitive disease, large trials with next-generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastos, Diogo A, Antonarakis, Emmanuel S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816030/
https://www.ncbi.nlm.nih.gov/pubmed/31695432
http://dx.doi.org/10.2147/OTT.S197244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816030/
https://www.ncbi.nlm.nih.gov/pubmed/31695432
http://dx.doi.org/10.2147/OTT.S197244

Ejemplares similares